We are live on ! Find out more
CCM

Cadence Capital Management Portfolio holdings

AUM $415M
1-Year Est. Return 11.01%
This Fund
S&P 500
This Quarter Est. Return
-2.82%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
AUM
$415M
AUM Growth
-$275M
Cap. Flow
-$256M
Cap. Flow %
-61.73%
Top 10 Hldgs %
38.46%
Holding
421
New
30
Increased
6
Reduced
240
Closed
144

Sector Composition

Rank Sector Weight
1 Energy 45.53%
2 Healthcare 9.95%
3 Consumer Staples 8.81%
4 Industrials 8.59%
5 Technology 7.87%

No holdings matched the selected filter criteria.

Similar funds

Cadence Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Cadence Capital Management held 421 positions worth $415M, down 40% from $689M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Cadence Capital Management withdrew a net $256M in Q3 2020, closing 144 positions and reducing 240 holdings. Its most notable exit was MasterCraft Boat Holdings, an estimated $2.18M position sold in full.

By sector, the portfolio is most concentrated in Energy at 46% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Cadence Capital Management opened a new position in Meridian Bioscience Inc worth $560K.

  • Cadence Capital Management's largest Q3 2020 buy was Meridian Bioscience Inc: 33,000 shares worth $560K.
  • Cadence Capital Management added most to MPLX in Q3 2020, an estimated $1.61M increase.
  • Cadence Capital Management's biggest Q3 2020 reduction was Castle Biosciences, cutting an estimated $2.4M.
  • Cadence Capital Management fully exited MasterCraft Boat Holdings in Q3 2020, selling an estimated $2.18M.
  • Cadence Capital Management's ten largest holdings make up 38% of its $415M portfolio in Q3 2020.
  • Cadence Capital Management opened 30 new positions and closed 144 in Q3 2020.
  • Cadence Capital Management's portfolio value fell 40% quarter-over-quarter to $415M.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.